FilingFirehose · free AI preview
Skye Bioscience, Inc.
SKYE · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Delisting
Skye Bioscience (SKYE) filed a delisting notice on May 15, 2026, marking a material adverse event in the past 90 days with no detected cyber incidents. The company's regulatory standing and operational continuity now require urgent scrutiny beyond the filing itself. The full $49 Report adds comprehensive delisting risk context, a dilution scoring analysis, 12-month financing history, and AI-detected regulatory signals that clarify whether this represents a temporary compliance issue or a terminal trajectory. The full $49 Report adds institutional-grade assessment of recovery probability and shareholder impact.
Want the full 5-section $49 Report on SKYE?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.